Examining how chemotherapy affects daily performance and executive functions in adults with cancer
Effects of Chemotherapy on Perceived Daily Performance and Executive Functions of Adults With Cancer
This study tests how chemotherapy affects daily activities and thinking skills in adults who have just been diagnosed with cancer.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 38 (estimated) |
| Ages | 18 Years to 75 Years |
| Sex | All |
| Sponsor | Bnai Zion Medical Center Government |
| Drugs / interventions | chemotherapy |
| Locations | 1 site (Haifa) |
| Trial ID | NCT05599698 on ClinicalTrials.gov |
What this trial studies
This study investigates the impact of chemotherapy on perceived daily performance and executive functioning in adults diagnosed with non-central nervous system cancers. Participants will be newly diagnosed individuals who are about to begin chemotherapy, and the study aims to assess changes in their cognitive and daily functioning as they undergo treatment. The research will involve evaluating patients' experiences and perceptions before and after chemotherapy to understand the effects on their quality of life.
Who should consider this trial
Good fit: Ideal candidates are adults newly diagnosed with primary non-central nervous system malignancies who are about to start chemotherapy.
Not a fit: Patients with central nervous system malignancies, previous malignancies, or significant neurological conditions may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide insights into how chemotherapy affects cognitive functions, potentially leading to better supportive care strategies for cancer patients.
How similar studies have performed: While studies on chemotherapy's effects on cognitive function exist, this specific focus on perceived daily performance in non-central nervous system cancers is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Newly diagnosed with a primary non-central nervous system malignancy (lung, breast, colon, ulcer, urinary tract, canine tumors). * Stages I-III. * Pre-commencement of adjuvant (post-surgery) or neoadjuvant (prior to surgery) chemotherapy. * Understand and read Hebrew. * Have at least 12 years of education. Exclusion Criteria: * Diagnosed with central nervous system malignancies. * Had a previous malignancy. * Have or had metastatic disease. * Have a history of a neurological condition or severe depression.
Where this trial is running
Haifa
- Bnai Zion Medical Center — Haifa, Israel (Recruiting)
Study contacts
- Principal investigator: Abed Agbarya, MD — abed.agbarya@b-zion.org.il
- Study coordinator: khawla loubani, PhD
- Email: khawlaloubani@gmail.com
- Phone: +97240504564402
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.